drugset / Trial / NCT02050334

CC100: Safety and Tolerability of Single Doses

NCT02050334 ↗

Phase 1 Completed 18 enrolled Chemigen, LLC
RandomizedParallel-groupSingle-blindBasic science

Summary

The purpose of this study is to see if CC100, given by mouth, is safe and is tolerated in increasing doses. How long the drug remains in the body will also be calculated.

Timeline

Start
2013-11
Primary completion
2014-07
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject CC100 Unknown — Oral

Indications

No indication recorded.